Your Location：Home > News

Pimobendan and Trilostane API obtained GMP certificate in September 2024
2025/01/07

Pimobendan and Trilostane API obtained GMP certificate in September 2024

Passed the third-party Audit of the USA customer in December 2024
2025/01/07

Passed the third-party Audit of the USA customer in December 2024

The national specialized new enterprise Panjin City has passed, and is now under review by the Liaoning Provincial Department.
2025/01/07
The national specialized new enterprise Panjin City has passed, and is now under review by the Liaoning Provincial Department.
Our products conform to Quality Management System Standard: GB/T19001-2016/ ISO9001:2015
2023/09/15

Address：No.20 Building, Area A ,Park Street South, Industry & Trade Road West Industrial Park, Shuangtaizi District, Panjin City, Liaoning Province,ChinaEmail：lancy@pipharma.com.cn;sales@pipharma.com.cn

Tel：022-66350830Phone：13322388077/+86-16588669988

Copyright © 2025 Liaoning Pharmaceutical Innovation Co.,Ltd All Rights Reserved. ICP NO.:Zhejiang000000